Does SITAGLIPTIN Cause Central venous catheterisation? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Central venous catheterisation have been filed in association with SITAGLIPTIN (JANUVIA). This represents 0.1% of all adverse event reports for SITAGLIPTIN.
14
Reports of Central venous catheterisation with SITAGLIPTIN
0.1%
of all SITAGLIPTIN reports
12
Deaths
14
Hospitalizations
How Dangerous Is Central venous catheterisation From SITAGLIPTIN?
Of the 14 reports, 12 (85.7%) resulted in death, 14 (100.0%) required hospitalization, and 4 (28.6%) were considered life-threatening.
Is Central venous catheterisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does SITAGLIPTIN Cause?
Blood glucose increased (1,427)
Pancreatic carcinoma (1,142)
Product dose omission issue (1,125)
Drug ineffective (1,057)
No adverse event (994)
Nausea (936)
Pancreatitis (922)
Diabetes mellitus inadequate control (744)
Diarrhoea (712)
Hypoglycaemia (674)
What Other Drugs Cause Central venous catheterisation?
EPOPROSTENOL (361)
AMBRISENTAN (263)
TREPROSTINIL (208)
ECULIZUMAB (105)
VENETOCLAX (89)
MACITENTAN (78)
PEMBROLIZUMAB (70)
AZTREONAM LYSINE (63)
ADALIMUMAB (59)
NATALIZUMAB (57)
Which SITAGLIPTIN Alternatives Have Lower Central venous catheterisation Risk?
SITAGLIPTIN vs SOAP
SITAGLIPTIN vs SODIUM
SITAGLIPTIN vs SODIUM BICARBONATE
SITAGLIPTIN vs SODIUM BICARBONATE\SODIUM
SITAGLIPTIN vs SODIUM BORATE